Trupanion, Inc.
TRUP- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001371285
In the last 90 days, Trupanion, Inc. insiders filed 0 open-market purchases and 7 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $836.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Trupanion, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 3 insiders, $381.2K in total
- Insiders trading
- 3
- Net value
- −$381.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Trupanion, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tooth Margaret | CEO | 185,952 | Sep 15, 2026 | 11 |
| Gallagher John R | Chief Operating Officer | 33,742 | Sep 1, 2026 | 16 |
| Rubin Howard E | Director | 233,288 | Aug 26, 2026 | 5 |
| Powell Bradley S | Director | 3,546 | Aug 26, 2026 | 6 |
| Bearman Asher | Chief Legal Officer | 74,013 | Aug 26, 2026 | 4 |
| Weinrauch Steve | EVP, North Am & Vet Strategy | 81,740 | Aug 26, 2026 | 7 |
| McGibney Brenna | Chief Administration Officer | 14,437 | Aug 26, 2026 | 6 |
| Wheeler Simon | EVP, Trupanion International | 25,327 | Aug 26, 2026 | 6 |
| Qureshi Fawwad | Chief Financial Officer | 4,230 | Aug 26, 2026 | 7 |
| Rawlings Darryl | Director | 25,151 | Aug 26, 2026 | 8 |
| McLaughlin Elizabeth | Director | 10,635 | May 13, 2026 | 1 |
| Dodson Paulette R. | Director | 8,526 | May 13, 2026 | 1 |
| Broden Max | Director | 8,571 | May 13, 2026 | 1 |
| Dreyer Emily | Chief Revenue Officer | 35,627 | Mar 6, 2026 | 5 |
| Low Murray B | Director | 154,534 | Jan 12, 2026 | 1 |
| Kearns Christopher J | Chief Legal Officer | 8,159 | Mar 3, 2025 | 0 |
| Hewitt Melissa Joy | General Manager | 9,779 | Mar 3, 2025 | 0 |
| Wasdin Jason | General Manager | 4,553 | Mar 3, 2025 | 0 |
| Davidson Jacqueline L | Director | 16,564 | Jan 3, 2025 | 0 |
| Worra Travis | General Manager | 4,179 | Nov 27, 2024 | 0 |
| Raval Kalpesh | General Manager | 3,886 | Nov 27, 2024 | 0 |
| Levitan Dan | Director | 95,116 | Apr 3, 2024 | 0 |
| Satchu Zay | Director | 4,788 | Apr 3, 2024 | 0 |
| Enthoven Richard | Director | 485 | Jan 3, 2024 | 0 |
| Doak Michael | Director | 5,866 | Sep 1, 2023 | 0 |
| Li Wei | Interim CFO | 4,909 | Aug 29, 2023 | 0 |
| Wolff Andrew D. | Chief Financial Officer | 7,895 | May 30, 2023 | 0 |
| Plouf Tricia | EVP, Pricing | 41,023 | Feb 10, 2023 | 0 |
| Friedman Gavin | EVP, Legal and Regulatory | 9,591 | Feb 3, 2023 | 0 |
| Johnson Eric L | Director | 2,691 | Jan 4, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Gallagher John RChief Operating Officer | SSale | −430 | $37.55 | −$16.1K | −1.3%32.3K after | 10b5-1 |
| Jan 29, 2026 (view filing) | Jan 28 | 1 day | Gallagher John RChief Operating Officer | SSale | −430 | $31.67 | −$13.6K | −1.3%31.9K after | 10b5-1 |
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Weinrauch SteveEVP, North Am & Vet Strategy | SSale | −85 | $26.70 | −$2.27K | −0.1%72.6K after | |
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Qureshi FawwadChief Financial Officer | SSale | −4.64K | $25.61 | −$119.0K | −100.0%0 after | |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Gallagher John RChief Operating Officer | SSale | −5.28K | $26.52 | −$140.1K | −14.0%32.4K after | |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Qureshi FawwadChief Financial Officer | SSale | −2.84K | $26.46 | −$75.1K | −100.0%0 after | |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Dreyer EmilyChief Revenue Officer | SSale | −7.79K | $28.15 | −$219.3K | −17.9%35.6K after | |
| Apr 1, 2026 (view filing) | Mar 30 | 2 days | Gallagher John RChief Operating Officer | SSale | −430 | $25.47 | −$11.0K | −1.3%32.0K after | |
| Apr 29, 2026 (view filing) | Apr 28 | 1 day | Gallagher John RChief Operating Officer | SSale | −431 | $27.47 | −$11.8K | −1.3%31.5K after | |
| May 27, 2026 (view filing) | May 27 | Same day | Qureshi FawwadChief Financial Officer | SSale | −6.18K | $22.18 | −$137.0K | −74.8%2.08K after | 2 lots |
| May 27, 2026 (view filing) | May 25 | 2 days | Tooth MargaretCEO | SSale | −491 | $21.86 | −$10.7K | −0.3%176.4K after | |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Gallagher John RChief Operating Officer | SSale | −3.60K | $21.69 | −$78.1K | −9.8%33.1K after | |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Weinrauch SteveEVP, North Am & Vet Strategy | SSale | −6.67K | $22.00 | −$146.8K | −7.9%78.1K after | |
| Jul 1, 2026 (view filing)7:09 PM ET | Jun 29 | 2 days | Gallagher John RChief Operating Officer | SSale | −431 | $25.35 | −$10.9K | −1.3%32.6K after | 10b5-1 |
| Jul 30, 2026 (view filing)5:44 PM ET | Jul 28 | 2 days | Gallagher John RChief Operating Officer | SSale | −431 | $25.08 | −$10.8K | −1.3%32.2K after | 10b5-1 |
| Aug 13, 2026 (view filing)6:44 PM ET | Aug 11 | 2 days | Tooth MargaretCEO | SSale | −978 | $29.05 | −$28.4K | −0.6%175.4K after | 10b5-1 |
| Aug 26, 2026 (view filing)6:56 PM ET | Aug 25 | 1 day | Tooth MargaretCEO | SSale | −491 | $31.84 | −$15.6K | −0.3%187.0K after | |
| Aug 26, 2026 (view filing)6:56 PM ET | Aug 26 | Same day | Qureshi FawwadChief Financial Officer | SSale | −6.11K | $30.01 | −$183.4K | −59.1%4.23K after | |
| Sep 1, 2026 (view filing)7:37 PM ET | Aug 28 | 4 days | Gallagher John RChief Operating Officer | SSale | −3.60K | $29.70 | −$107.0K | −9.7%33.7K after | 10b5-1 |
| Sep 15, 2026 (view filing)6:55 PM ET | Sep 11 | 4 days | Tooth MargaretCEO | SSale | −1.00K | $25.00 | −$25.0K | −0.5%186.0K after | 10b5-1 |